| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID195690 | Ability to displace 7.0 nM [3H]PCP binding to rat brain homogenate relative to PCP (IC50= 270 nM) | 1981 | Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
| Structure-activity relationships of the cycloalkyl ring of phencyclidine. |
| AID195553 | Inhibitory concentration for [3H]PCP binding to rat brain homogenate relative to PCP | 1981 | Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
| Structure-activity relationships of the cycloalkyl ring of phencyclidine. |
| AID74940 | Tested for its effect on Hypoxia induced neuronal damage | 1990 | Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
| 2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents. |
| AID23796 | Half-life determined in the urine of monkey | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Mammalian metabolism of phencyclidine. |
| AID23795 | Half-life determined in the urine of dog | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Mammalian metabolism of phencyclidine. |
| AID57330 | Compound was evaluated for the mean locomotor activity (GABA-ergic agonism) by the difference in the counts between postinjection and preinjection activities. | 1981 | Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
| Mammalian metabolism of phencyclidine. |
| AID74941 | Tested for its effect on hippocampal neuronal damage in gerbils activity | 1990 | Journal of medicinal chemistry, Oct, Volume: 33, Issue:10
| 2,4-Dihydro-3H-1,2,4-triazol-3-ones as anticonvulsant agents. |
| AID187492 | Relative potency in the rat discriminative stimulus assay, expressed as mg of PCP (= 1.0 mg of compound) | 1981 | Journal of medicinal chemistry, Dec, Volume: 24, Issue:12
| Structure-activity relationships of the cycloalkyl ring of phencyclidine. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |